|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 28,1997 PSA#1833Defense Advanced Research Projects Agency (DARPA), Contracts Management
Office (CMO), 3701 N. Fairfax Dr., Arlington, VA 22203-1714 A -- ADVANCED DIAGNOSTICS FOR PATHOGENS SOL BAA97-24 DUE 091197 POC
Stephen S. Morse, Ph.D., fax:(803) 974-5445; POC for contractual
matters is Mr. Tom Baranoski, fax -- (803) 974-5445 Defense Advanced
Research Projects Agency (DARPA), DARPA BAA 97-24: ADVANCED DIAGNOSTICS
FOR PATHOGENS. POC for technical matters is Stephen S. Morse, Ph.D.,
fax: (803) 974-5445; e-mail: BAA9724T@niseeast.nosc.mil. POC for
contractual matters is Mr. Tom Baranoski at; fax -- (803) 974-5445;
e-mail -- BAA9724C@niseeast.nosc.mil. The purpose of this modification
to BAA 97-24 is to amend Section 1, page 5 to read as
follows:PROPOSAL: The objective of a successful proposal is a
feasibility demonstration of the technology proposed for development.
Proposers must describe in detail the technical and scientific basis of
the diagnostic methodology or instrument under development (Phase 1)
and the details of the technology demonstration using clinically
relevant sample types or suitable animal models (Phase 2). All programs
must culminate in a significant end-point demonstration of solutions to
crucial problems within the initial period of support. (0114) Loren Data Corp. http://www.ld.com (SYN# 0003 19970428\A-0003.SOL)
A - Research and Development Index Page
|
|